BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND AFP, AFPD, FETA, HPAFP AND Prognosis
16 results:

  • 1. kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study.
    Zhang L; Su K; Liu Q; Li B; Wang Y; Cheng C; Li Y; Xu C; Chen J; Wu H; Zhu M; Mai X; Cao Y; Peng J; Yue Y; Ding Y; Yu D
    BMC Cancer; 2023 Nov; 23(1):1081. PubMed ID: 37946141
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment.
    Jiang Y; Wang Y; Wang Z; Zhang Y; Hou Y; Wang X
    Sci Rep; 2023 Nov; 13(1):18909. PubMed ID: 37919386
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Surgical diagnosis and treatment of adult huge undifferentiated embryonal sarcoma of the liver].
    Pu T; Chen JM; Guo Q; Yang LJ; Geng XP; Liu FB
    Zhonghua Wai Ke Za Zhi; 2021 Oct; 59(10):848-853. PubMed ID: 34619911
    [No Abstract]    [Full Text] [Related]  

  • 4. Childhood ovarian nonseminomatous germ cell tumors: A highly curable disease with few long-term treatment-related toxicities-Results of the French TGM95 study.
    Pavone R; Pacquement H; Pasquet M; Sudour-Bonnange H; Hameury F; Sarnacki S; Chastagner P; Faure-Conter C; Poirée M; Taque S; Patte C; Fresneau B
    Int J Cancer; 2021 Nov; 149(9):1705-1712. PubMed ID: 34146403
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hepatoid adenocarcinoma of the renal pelvis in a 59-year-old male with nephrolithiasis: Case report and review of the literature.
    Huang J; Zhu R; Wu R; Li R; Yao N; Deng S
    Curr Probl Cancer; 2019 Oct; 43(5):471-476. PubMed ID: 30683324
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical efficacy of endovascular radiofrequency ablation in the treatment of portal vein tumor thrombus of primary hepatocellular carcinoma.
    Chen ZW; Lin ZY; Chen YP; Chen J; Chen J
    J Cancer Res Ther; 2018 Jan; 14(1):145-149. PubMed ID: 29516977
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
    Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
    Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Rare extragonadal teratomas in children: complete tumor excision as a reliable and essential procedure for significant survival. Clinical experience and review of the literature.
    Paradies G; Zullino F; Orofino A; Leggio S
    Ann Ital Chir; 2014; 85(1):56-68. PubMed ID: 23165250
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Serotonin used as prognostic marker of urological tumors.
    Jungwirth N; Haeberle L; Schrott KM; Wullich B; Krause FS
    World J Urol; 2008 Oct; 26(5):499-504. PubMed ID: 18581119
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Collecting duct carcinoma of kidney producing alpha-fetoprotein.
    Blandamura S; Vendraminelli R; Aversa S; Fedrigo M
    Eur J Surg Oncol; 2005 Nov; 31(9):1039-41. PubMed ID: 16126361
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Phase I clinical trial of targeted therapy using 131I-Hepama-1 mAb in patients with hepatocellular carcinoma.
    Chen S; Li B; Xie H; Xu L; Niu G; Fan K; Fan Q
    Cancer Biother Radiopharm; 2004 Oct; 19(5):589-600. PubMed ID: 15650451
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Significance of current bio- and molecular-markers in urological cancers].
    Shimazui T; Akaza H
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1008-14. PubMed ID: 15272577
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Surgical approach to posthepatitic cirrhotic patient today].
    Meriggi F; Forni E
    G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Prognostic factors in genitourinary cancer].
    Kotake T; Miki T; Kuroda M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2216-23. PubMed ID: 3408256
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Significance of tumor markers in the treatment of urological malignancies].
    Akaza H; Kameyama S; Aso Y
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3034-40. PubMed ID: 2445294
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [A clinical study of renal tumors].
    Tamai H; Ogawa T; Mitsui H; Nagakubo I
    Hinyokika Kiyo; 1983 Oct; 29(10):1255-68. PubMed ID: 6681500
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.